EQUASENS (EQS.PA) Stock Fundamental Analysis
Europe - EPA:EQS - FR0012882389 - Common Stock
40.25 EUR
+3.4 (+9.23%)
Overall EQS gets a fundamental rating of 6 out of 10. We evaluated EQS against 10 industry peers in the Health Care Technology industry. EQS has an excellent profitability rating, but there are some minor concerns on its financial health. EQS has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
EQS had positive earnings in the past year.
EQS had a positive operating cash flow in the past year.
In the past 5 years EQS has always been profitable.
EQS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
EQS has a Return On Assets of 8.84%. This is in the better half of the industry: EQS outperforms 70.00% of its industry peers.
The Return On Equity of EQS (15.79%) is better than 80.00% of its industry peers.
EQS's Return On Invested Capital of 12.70% is amongst the best of the industry. EQS outperforms 90.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EQS is significantly above the industry average of 9.03%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.84% | ||
| ROE | 15.79% | ||
| ROIC | 12.7% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
1.3 Margins
With a decent Profit Margin value of 16.15%, EQS is doing good in the industry, outperforming 80.00% of the companies in the same industry.
In the last couple of years the Profit Margin of EQS has remained more or less at the same level.
EQS has a Operating Margin of 19.80%. This is amongst the best in the industry. EQS outperforms 90.00% of its industry peers.
EQS's Operating Margin has declined in the last couple of years.
EQS has a worse Gross Margin (68.81%) than 70.00% of its industry peers.
EQS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.8% | ||
| PM (TTM) | 16.15% | ||
| GM | 68.81% |
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EQS is still creating some value.
EQS has about the same amout of shares outstanding than it did 1 year ago.
EQS has more shares outstanding than it did 5 years ago.
EQS has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.67 indicates that EQS is not in any danger for bankruptcy at the moment.
EQS has a better Altman-Z score (3.67) than 70.00% of its industry peers.
The Debt to FCF ratio of EQS is 0.98, which is an excellent value as it means it would take EQS, only 0.98 years of fcf income to pay off all of its debts.
EQS has a Debt to FCF ratio of 0.98. This is in the better half of the industry: EQS outperforms 70.00% of its industry peers.
EQS has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
EQS's Debt to Equity ratio of 0.09 is in line compared to the rest of the industry. EQS outperforms 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.98 | ||
| Altman-Z | 3.67 |
ROIC/WACC1.13
WACC11.19%
2.3 Liquidity
A Current Ratio of 1.29 indicates that EQS should not have too much problems paying its short term obligations.
The Current ratio of EQS (1.29) is worse than 60.00% of its industry peers.
EQS has a Quick Ratio of 1.20. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
EQS's Quick ratio of 1.20 is on the low side compared to the rest of the industry. EQS is outperformed by 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.2 |
3. Growth
3.1 Past
EQS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.07%.
EQS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.12% yearly.
EQS shows a small growth in Revenue. In the last year, the Revenue has grown by 4.45%.
Measured over the past years, EQS shows a small growth in Revenue. The Revenue has been growing by 6.45% on average per year.
EPS 1Y (TTM)-14.07%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%
3.2 Future
Based on estimates for the next years, EQS will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.63% on average per year.
The Revenue is expected to grow by 7.74% on average over the next years.
EPS Next Y18.72%
EPS Next 2Y19.01%
EPS Next 3Y18.63%
EPS Next 5YN/A
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 16.84, which indicates a correct valuation of EQS.
Based on the Price/Earnings ratio, EQS is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
EQS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.13.
EQS is valuated correctly with a Price/Forward Earnings ratio of 12.40.
80.00% of the companies in the same industry are more expensive than EQS, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.35, EQS is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.84 | ||
| Fwd PE | 12.4 |
4.2 Price Multiples
80.00% of the companies in the same industry are more expensive than EQS, based on the Enterprise Value to EBITDA ratio.
EQS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. EQS is cheaper than 70.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.44 | ||
| EV/EBITDA | 7.4 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of EQS may justify a higher PE ratio.
EQS's earnings are expected to grow with 18.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.9
PEG (5Y)3.29
EPS Next 2Y19.01%
EPS Next 3Y18.63%
5. Dividend
5.1 Amount
EQS has a Yearly Dividend Yield of 3.31%.
The stock price of EQS dropped by -26.74% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 3.43, EQS pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.39, EQS pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.31% |
5.2 History
The dividend of EQS is nicely growing with an annual growth rate of 8.00%!
Dividend Growth(5Y)8%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
51.75% of the earnings are spent on dividend by EQS. This is a bit on the high side, but may be sustainable.
The dividend of EQS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP51.75%
EPS Next 2Y19.01%
EPS Next 3Y18.63%
EPA:EQS (11/6/2025, 2:48:56 PM)
40.25
+3.4 (+9.23%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners11.62%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap610.59M
Revenue(TTM)224.73M
Net Income(TTM)36.30M
Analysts80
Price Target49.98 (24.17%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.31% |
Yearly Dividend1.25
Dividend Growth(5Y)8%
DP51.75%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.01%
PT rev (3m)-14.04%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-6.75%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.84 | ||
| Fwd PE | 12.4 | ||
| P/S | 2.72 | ||
| P/FCF | 16.44 | ||
| P/OCF | 12.65 | ||
| P/B | 2.66 | ||
| P/tB | 7.64 | ||
| EV/EBITDA | 7.4 |
EPS(TTM)2.39
EY5.94%
EPS(NY)3.25
Fwd EY8.07%
FCF(TTM)2.45
FCFY6.08%
OCF(TTM)3.18
OCFY7.9%
SpS14.81
BVpS15.16
TBVpS5.27
PEG (NY)0.9
PEG (5Y)3.29
Graham Number28.55
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.84% | ||
| ROE | 15.79% | ||
| ROCE | 15.59% | ||
| ROIC | 12.7% | ||
| ROICexc | 17.92% | ||
| ROICexgc | 69.44% | ||
| OM | 19.8% | ||
| PM (TTM) | 16.15% | ||
| GM | 68.81% | ||
| FCFM | 16.53% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
ROICexc(3y)19.36%
ROICexc(5y)21.38%
ROICexgc(3y)50.59%
ROICexgc(5y)62.81%
ROCE(3y)18.64%
ROCE(5y)19.75%
ROICexgc growth 3Y-25.09%
ROICexgc growth 5Y-9.54%
ROICexc growth 3Y-15.77%
ROICexc growth 5Y-10.18%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.98 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | 69.34% | ||
| Cap/Sales | 4.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 79.71% | ||
| Profit Quality | 102.29% | ||
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.2 | ||
| Altman-Z | 3.67 |
F-Score7
WACC11.19%
ROIC/WACC1.13
Cap/Depr(3y)96.13%
Cap/Depr(5y)118.08%
Cap/Sales(3y)6.18%
Cap/Sales(5y)7.08%
Profit Quality(3y)94.47%
Profit Quality(5y)93.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-14.07%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
EPS Next Y18.72%
EPS Next 2Y19.01%
EPS Next 3Y18.63%
EPS Next 5YN/A
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
EBIT growth 1Y-8.02%
EBIT growth 3Y-4.55%
EBIT growth 5Y1.4%
EBIT Next Year59.12%
EBIT Next 3Y27.46%
EBIT Next 5YN/A
FCF growth 1Y-36.73%
FCF growth 3Y-1.08%
FCF growth 5Y8.7%
OCF growth 1Y-31.7%
OCF growth 3Y0.02%
OCF growth 5Y3.18%
EQUASENS / EQS.PA FAQ
What is the ChartMill fundamental rating of EQUASENS (EQS.PA) stock?
ChartMill assigns a fundamental rating of 6 / 10 to EQS.PA.
What is the valuation status for EQS stock?
ChartMill assigns a valuation rating of 6 / 10 to EQUASENS (EQS.PA). This can be considered as Fairly Valued.
What is the profitability of EQS stock?
EQUASENS (EQS.PA) has a profitability rating of 7 / 10.
What is the expected EPS growth for EQUASENS (EQS.PA) stock?
The Earnings per Share (EPS) of EQUASENS (EQS.PA) is expected to grow by 18.72% in the next year.
Can you provide the dividend sustainability for EQS stock?
The dividend rating of EQUASENS (EQS.PA) is 6 / 10 and the dividend payout ratio is 51.75%.